Mirja Dombrowski1, Matthias May2, Philipp Julian Spachmann3, Manju Ganesh Kumar3, Hans-Martin Fritsche4, Sabine Brookman-May5, Odilo Maurer2, Maximilian Burger3, Christian Gilfrich2. 1. Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Cardiology, Barmherzige Brüder Hospital Regensburg, Regensburg, Germany. Electronic address: mirja.kristin@gmx.de. 2. Department of Urology, St Elisabeth Hospital Straubing, Straubing, Germany. 3. Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany. 4. Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Urology, Surgical Clinic Munich-Bogenhausen, Munich, Germany. 5. Department of Urology, Ludwig-Maximilians-University, Campus Grosshadern, Munich, Germany; Janssen Pharma Research and Development, Los Angeles, CA.
Abstract
PURPOSE: Our objective was to investigate whether patients with urologic tumors were aware of smoking as a risk factor for the development and progression of several urologic cancers and the extent of the medical education they had received. Another aim was to investigate whether gender or age influenced patients' willingness to change their smoking habits. MATERIALS AND METHODS: Patients with histologically malignant urologic tumors were enrolled in our questionnaire-based study from September 2013 to December 2014 in 2 urology departments. Patients were asked about their smoking habits and their general understanding of the relationship between smoking and the onset of cancer (urologic cancer and lung cancer). Also, the extent of information they had acquired from a physician was assessed. The descriptive and oncologic data of the patients were recorded. RESULTS: Of 258 enrolled patients, 186 (72.1%) had never had an informational discussion with a doctor about smoking and their urologic tumor disease. Of the 160 active and former smokers, only 45 (28.1%) were planning to stop or reduce smoking because of their tumor disease. The willingness to change smoking habits was greater for women, with a statistically significant difference (odds ratio, 5.59; P = .002). Younger patients aged <58 years were also more willing to reduce or stop smoking. CONCLUSION: In our study, most patients with urologic cancer were unaware of smoking as the most probable cause of tumor development. The patients had not received proper counseling from doctors on smoking and the risk it poses for tumor progression. Efforts to balance compliance among the genders and age groups through risk-adapted counseling should be undertaken.
PURPOSE: Our objective was to investigate whether patients with urologic tumors were aware of smoking as a risk factor for the development and progression of several urologic cancers and the extent of the medical education they had received. Another aim was to investigate whether gender or age influenced patients' willingness to change their smoking habits. MATERIALS AND METHODS:Patients with histologically malignant urologic tumors were enrolled in our questionnaire-based study from September 2013 to December 2014 in 2 urology departments. Patients were asked about their smoking habits and their general understanding of the relationship between smoking and the onset of cancer (urologic cancer and lung cancer). Also, the extent of information they had acquired from a physician was assessed. The descriptive and oncologic data of the patients were recorded. RESULTS: Of 258 enrolled patients, 186 (72.1%) had never had an informational discussion with a doctor about smoking and their urologic tumor disease. Of the 160 active and former smokers, only 45 (28.1%) were planning to stop or reduce smoking because of their tumor disease. The willingness to change smoking habits was greater for women, with a statistically significant difference (odds ratio, 5.59; P = .002). Younger patients aged <58 years were also more willing to reduce or stop smoking. CONCLUSION: In our study, most patients with urologic cancer were unaware of smoking as the most probable cause of tumor development. The patients had not received proper counseling from doctors on smoking and the risk it poses for tumor progression. Efforts to balance compliance among the genders and age groups through risk-adapted counseling should be undertaken.
Authors: Christian Gilfrich; Odilo Maurer; Philipp J Spachmann; Mirja K Dombrowski; Maximilian Burger; Matthias May Journal: World J Urol Date: 2018-08-11 Impact factor: 4.226